HIGH PROLACTIN LEVELS IN PATIENTS WITH CUSHINGS-DISEASE WITHOUT PATHOLOGICAL EVIDENCE OF PITUITARY-ADENOMA

Citation
R. Comtois et al., HIGH PROLACTIN LEVELS IN PATIENTS WITH CUSHINGS-DISEASE WITHOUT PATHOLOGICAL EVIDENCE OF PITUITARY-ADENOMA, Clinical endocrinology, 38(6), 1993, pp. 601-607
Citations number
42
Categorie Soggetti
Endocrynology & Metabolism
Journal title
ISSN journal
03000664
Volume
38
Issue
6
Year of publication
1993
Pages
601 - 607
Database
ISI
SICI code
0300-0664(1993)38:6<601:HPLIPW>2.0.ZU;2-Y
Abstract
OBJECTIVE This study was designed to compare the clinical and biochemi cal features of patients with Cushing's disease without pathological e vidence of pituitary adenoma (n = 11) to those in whom a pituitary ACT H adenoma was documented (n = 11). DESIGN The clinical and biochemical features of 11 patients with Cushing's disease without pathological e vidence of pituitary adenomas were compared to 11 subjects with ACTH-s ecreting adenomas. The patients underwent transsphenoidal microsurgery between 1979 and 1989. During surgery, when an adenoma was not visual ized, a partial hypophysectomy of the central mucoid wedge was perform ed. MEASUREMENTS Cushing's disease was established by the clinical fea tures of hypercortisolism and the high levels of 24-hour free urinary cortisol with no suppression in response to low, but with suppression in response to high, doses of dexamethasone. Basal and post TRH-GnRH p lasma prolactin, FSH and LH levels were assessed in each patient befor e transsphenoidal microsurgery. RESULTS Similar results were observed in patients with and without ACTH-secreting adenomas regarding cure ra te, and free urinary cortisol levels both basal and after 2 days of de xamethasone, 8 mg daily. After surgery, plasma cortisol levels in cure d patients were lower in subjects with ACTH-secreting adenomas than in those without pituitary tumours (P < 0.05). Areas under the curve of PRL (P < 0.002) and LH (P < 0.04) were significantly higher in patient s without pituitary adenoma after TRH-GnRH administration. Compared to controls, the peak prolactin level after TRH-GnRH administration was higher in patients without pituitary adenoma (P < 0.005) and lower in those with ACTH adenoma (P < 0.005). Furthermore, a peak prolactin lev el equal to or greater than 1410 mU/l during the TRH-GnRH test was fou nd in 11/11 patients without ACTH adenoma and 3/11 patients in the oth er group (P < 0.001), while the CT-scan findings were suggestive of pi tuitary adenoma in six patients of each group. CONCLUSION This study s uggests that patients with Cushing's disease without pituitary adenoma s can be distinguished from those with ACTH-secreting adenomas by thei r high prolactin levels after TRH-GnRH administration.